
    
      To assess the safety and performance of the JOURNEY™ II UNI UKS in patients with
      unicompartmental degeneration of the knee by demonstrating non-inferiority of the cumulative
      percent implant survival in subjects with the JOURNEY™ II UNI UKS implanted, compared to a
      literature reference rate of 91.7% (AOA annual report 2015)12 at 5 years.
    
  